🔎 Trials Near Me

Home › Hereditary Sensory and Autonomic Neuropathies › Texas › Houston

Pag-aaral pangklinika para sa Hereditary Sensory and Autonomic Neuropathies sa Houston, TX

Isang pag-aaral para sa Hereditary Sensory and Autonomic Neuropathies ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of ACR-2316 in Specific Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06667141

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Nagre-recruitPhase 2
  • Houston Methodist Hospital, Houston
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

Nagre-recruitPhase 1
  • Research Site, Houston
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT07064122

Pag-aaral para sa Hereditary Sensory and Autonomic Neuropathies sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.